The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.
InvestorsHub on MSN
Eli Lilly plans $3 billion China investment, files for approval of new GLP-1 treatment
Eli Lilly and Company (NYSE:LLY) said it intends to invest about $3 billion in China over the next ten years to expand ...
The forces reshaping the global economy—in trade, geopolitics, technology, and demographics—are moving faster than at any point in recent history. However, as recent weeks have shown, this era of ...
When China’s National People’s Congress convened in Beijing last week to review the draft outline of the 15th Five-Year Plan ...
The city welcomed a batch of new regional headquarters and R&D centres this week, as China continues its campaign to win back ...
Ahead of its 15th Five-Year Plan, China has completed a structural shift in its financial system, moving from rapid expansion ...
By Yantoultra Ngui and Kane Wu SINGAPORE, March 17 (Reuters) - JPMorgan Chase has hired Yi Zhang from Goldman Sachs as ...
Arabian Post on MSN
China’s 2026 Government Work Report Indicates a New Cycle of Quality Enhancement for Commercial Real Estate Stock
Cushman & Wakefield Interpretation Report Highlights Eight Impact Areas for Real Estate MarketHONG KONG SAR – Media OutReach Newswire – 20 March 2026 – Global real estate services firm Cushman & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results